期刊文献+

P53及MVD与肝细胞性肝癌肝移植术后肿瘤复发的关系

Correlation of P53 and MVD with tumor recurrence after liver transplantation in patients with hepatocellular carcinoma
原文传递
导出
摘要 目的探讨肝细胞性肝癌(HCC)中P53蛋白表达及肿瘤微血管密度(MVD)与HCC肝移植术后肿瘤复发的关系。方法采用免疫组化检测HCC组织中P53蛋白表达,CD34标记癌组织血管内皮细胞,计算MVD,统计分析两者及临床病理因素与肝移植术后肿瘤复发的关系、两者与临床病理因素之间及两者相互之间的关系。结果单因素分析表明P53蛋白表达、MVD、肿瘤TNM分期及肿瘤脉管浸润对HCC肝移植术后肿瘤复发均有影响(P〈0.05),多因素分析后,仅P53和MVD为独立的影响因素;P53蛋白表达和MVD与肿瘤脉管浸润显著正相关(P〈0.05);P53蛋白表达阳性的肝癌组织MVD显著高于阴性表达者(P=0.01)。结论P53蛋白表达和MVD对预测HCC肝移植术后的肿瘤复发有重要价值;P53蛋白表达阳性和高MVD者易出现肿瘤脉管浸润;P53蛋白表达与肿瘤血管生成密切相关。 Objective To explore the role of P53 and MVD in predicting recurrence of hepato- cellular carcinoma (HCC) following orthotopic liver transplantation (OLT). Methods Forty patients with HCC who underwent OLT between 2003 and 2004 with a minimum clinical follow up of 18 months were included in this retrospective study. Tissue samples were immunohistochemically stained with P53. Tumor microvessel density (MVD) was evaluated by using CD34. Statistical analysis was performed to identify the relevant factors of tumor recurrence and the relation of P53 and MVD to clin-icopathological features. Results The univariate analysis showed that P53-posltivity (P 0. 025), MVD (P=0. 001) , pTNM (P=0. 022) and vascular invasion (P 0. 027) were significantly associated with the tumor recurrence of HCC after OLT. The multivariate logistic regression analysis indicated that only P53-positivity and MVD were significant predictors in predicting HCC recurrence. P53 expression and MVD were closely correlated to vascular invasion (P〈0.05). MVD was significantly higher in P53-positive HCC than that in P53-negative one (P〈0.05). Conclusion P53 and MVD may be the predictors for the recurrence of HCC after OLT. P53 expression and MVD are closely correlated to vascular invasion. P53 expression is positively associated with MVD.
出处 《中华肝胆外科杂志》 CAS CSCD 2008年第6期391-394,共4页 Chinese Journal of Hepatobiliary Surgery
基金 本课题受广东省科技计划项目基金资助(基金编号:2006B36003012)
关键词 肝移植 P53 微血管密度 肝细胞性肝癌 复发 Liver transplantation P53 MVD Hepatocellular carcinoma Recurrence
  • 相关文献

参考文献14

  • 1Lo CM, Fan ST. Liver transplantation for hepatocellular car einoma. Br J Surg, 2004, 91:131-133.
  • 2Weidner N. Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol, 1998, 184;119-122.
  • 3Park NH, Chung YH, Youn KH, et al. Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma. J Clin Gastroenterol, 2001, 33:397-401.
  • 4Poon RT, Ng IO, Lau C, et al. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: A prospective study. J Clin Oncol, 2002, 20:1775-1785.
  • 5Jeng KS, Sheen IS, Chen BF, et al. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? Arch Surg, 2000, 135:1329-1333.
  • 6潘运龙,覃莉.VEGF p53蛋白表达和MVD在肝细胞肝癌术后转移复发中的意义[J].中国现代医学杂志,2005,15(8):1223-1226. 被引量:7
  • 7Guzman G, Alagiozian-Angelova V, Layden-Almerp JE, et al. P53, Ki-67, and serum alpha feto-protein as predictors of hepatocellular carcinoma recurrence in liver transplant patients. Mod Pathol, 2005,18:1498-1503.
  • 8黄晓武,樊嘉,吴志全,孙惠川,汤钊猷.肝细胞肝癌与局灶性结节性增生微血管的免疫组化染色比较[J].中华肝胆外科杂志,2004,10(11):756-758. 被引量:16
  • 9Sun HC, Tang ZY, Li XM, et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 1999, 125:419-426.
  • 10Zhang Q, Chen XG, Zhou J, et al. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients. Cancer Biol Ther, 2006, 5:808-814.

二级参考文献20

  • 1计勇,甄作均,苏树英,许卓明,陈焕伟,周永辉.肝癌肝移植术中的无瘤操作技巧[J].岭南现代临床外科,2003,3(4):296-297. 被引量:3
  • 2夏穗生.重视外科感染的预防和治疗[J].中国实用外科杂志,2004,24(6):321-322. 被引量:13
  • 3潘运龙,覃莉,李文生.肝细胞肝癌中VEGF、p53、mdm2蛋白表达及其相互关系[J].实用肿瘤杂志,2004,19(4):288-291. 被引量:10
  • 4Mazzaferro V, Regalia E, Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirhosis. N Engl J Med, 1996, 334:693-699.
  • 5Ojogho ON, So SK, Keeffe EB, et al. Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg, 1996, 131:935-939.
  • 6Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of prognostic scoring system. J Am Coil Surg, 2000, 191:389-394.
  • 7Achkar JP. Araya V. Baron RL. et al. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transpl Surg. 1998, 4;477-482.
  • 8Ismail T, Angrisani L, Gunson BK, et al. Primary hepatic malignancy: the role of liver transplantation. Br J Surg, 1990,77: 983.
  • 9Marsh JW, Dovorchik I, Bonham CA, et al. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer, 2000, 88;538.
  • 10Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma; the tumor-node-metastasis classification does have prognostic power. Hepatology, 1998,27; 1572-1577.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部